TILLA S. WORGALL^^Associate Professor of Pathology and Cell Biology

Tilla Worgall.png

Tilla S. Worgall obtained an MD and PhD degree at the University of Heidelberg Germany in 1991, completed residency in Internal Medicine and came to Columbia University in 1995 as a post-doc.  She joined the lab of Richard Deckelbaum and focused on lipid biology.  She completed a residency in Pathology and became faculty in the Department of Pathology and Cell Biology in 2005.  Her time is divided between work as a clinical pathologist and PI of a research lab, where she focuses on role of lipids in mechanisms of disease and applications of aptamers in clinical chemistry.  Tilla is a co-inventor, with colleagues from Columbia, of several technologies that are currently being pursued through start-up companies.  The first such application has been the development of a point of care  monitoring for patients with phenylketonuria, a long standing unmet clinical need.   Another one, that is just taking off, is new personalized technology is .for monitoring of minimal residual disease in cancer patients.   Initial development of these technologies was supported through various internal funding mechanisms, such as Columbia Initiative in Personalized Medicine and Columbia Coulter Initiative. 

See Tilla in action at #StartupColumbia

2018 Keynote: Columbia Women Inventors
2018 Keynote: From Innovation to Spinout; Life at the Intersection of University Research and Entrepreneurship